TETRACAINE and BLINDNESS

Overview

BLINDNESS is the #20 most commonly reported adverse reaction for TETRACAINE, manufactured by Bellus Medical, LLC. There are 11 FDA adverse event reports linking TETRACAINE to BLINDNESS. This represents approximately 1.3% of all 876 adverse event reports for this drug.

Patients taking TETRACAINE who experience blindness should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

BLINDNESS is a less commonly reported adverse event for TETRACAINE, but still significant enough to appear in the safety profile.

Other Side Effects of TETRACAINE

In addition to blindness, the following adverse reactions have been reported for TETRACAINE:

• OFF LABEL USE — 46 reports
• ENDOPHTHALMITIS — 32 reports
• INFLAMMATION — 24 reports
• VISION BLURRED — 24 reports
• CORNEAL EPITHELIUM DEFECT — 22 reports
• TOXIC ANTERIOR SEGMENT SYNDROME — 20 reports
• VISUAL IMPAIRMENT — 19 reports
• DRUG HYPERSENSITIVITY — 18 reports
• EYE PAIN — 18 reports
• HEADACHE — 18 reports

Other Drugs Associated with BLINDNESS

The following drugs have also been linked to blindness in FDA adverse event reports:

Does TETRACAINE cause BLINDNESS?

BLINDNESS has been reported as an adverse event in 11 FDA reports for TETRACAINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is BLINDNESS with TETRACAINE?

BLINDNESS accounts for approximately 1.3% of all adverse event reports for TETRACAINE, making it a notable side effect.

What should I do if I experience BLINDNESS while taking TETRACAINE?

If you experience blindness while taking TETRACAINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages